JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1988) 117, 245-252       DOI: 10.1677/joe.0.1170245
© 1988 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miki, N.
Right arrow Articles by Shizumen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miki, N.
Right arrow Articles by Shizumen, K.

Withdrawal of endogenous somatostatin induces secretion of growth hormone-releasing factor in rats

N. Miki, M. Ono and K. Shizumen

Secretion of GH occurs in episodic bursts under the dual control of two hypothalamic peptides, GH-releasing factor (GRF) and GH-inhibiting factor (somatostatin, SRIF). Recent studies in rats suggest that episodic GH secretion is generated by the periodic release of GRF, which is associated with the simultaneous withdrawal of SRIF secretion. To test the possibility that GRF discharge is functionally coupled with the withdrawal of SRIF, we investigated whether acute withdrawal of SRIF can induce GRF release by the rat hypothalamus using highly specific antisera against SRIF and rat GRF. In conscious unrestrained rats, i.v. administration of SRIF antiserum at the period of the GH trough induced a rapid onset of the GH secretory surge with a peak value of 309 ± 67 µg/l (mean ± S.E.M.) 30 min after injection. Pretreatment with antiserum to rat GRF resulted in a ~83% suppression of the GH surge induced by SRIF antiserum without affecting the trough GH values. GRF antiserum also significantly inhibited the spontaneous GH surge. In urethane-anaesthetized rats, as in conscious rats, an acute phasic GH release was caused by SRIF antiserum despite the interference of anaesthesia with spontaneous GH secretion. A further surge-like GH secretion was not restored during the next several hours, however, with the GH secretory profile being characterized by a tonic increase in the baseline levels of GH. In the anaesthetized rat antiserum to rat GRF, having no effect on basal GH levels, similarly inhibited by ~66% the acute GH surge induced by SRIF antiserum and decreased by about 30% the later sustained rise in GH.

These results indicate that an acute rather than a chronic withdrawal of SRIF can trigger the phasic discharge of GRF by the hypothalamus, and raise the possibility that SRIF, originally isolated as a hypothalamic hypophysiotrophic GH-inhibiting factor, also acts as a GRF-inhibiting factor within the hypothalamus. We suggest that the episodic GH secretion may be initiated by an acute disinhibition of GRF secretion caused by the sudden withdrawal of SRIF.

J. Endocr. (1988) 117, 245–252




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. D. Veldhuis, S. A. Hudson, J. N. Bailey, and D. Erickson
Regulation of basal, pulsatile, and entropic (patterned) modes of GH secretion in a putatively low-somatostatin milieu in women
Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E483 - E489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. S. Farhy, C. Y. Bowers, and J. D. Veldhuis
Model-projected mechanistic bases for sex differences in growth hormone regulation in humans
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1577 - R1593.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, L. Farhy, A. L. Weltman, J. Kuipers, J. Weltman, and L. Wideman
Gender Modulates Sequential Suppression and Recovery of Pulsatile Growth Hormone Secretion by Physiological Feedback Signals in Young Adults
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2874 - 2881.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. S. Farhy and J. D. Veldhuis
Putative GH pulse renewal: periventricular somatostatinergic control of an arcuate-nuclear somatostatin and GH-releasing hormone oscillator
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1030 - R1042.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, S. M. Anderson, J. T. Patrie, and C. Y. Bowers
Estradiol Supplementation in Postmenopausal Women Doubles Rebound-Like Release of Growth Hormone (GH) Triggered by Sequential Infusion and Withdrawal of Somatostatin: Evidence that Estrogen Facilitates Endogenous GH-Releasing Hormone Drive
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 121 - 127.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
H. E. Pruett, D. L. Thompson Jr., J. A. Cartmill, C. C. Williams, and L. R. Gentry
Thyrotropin releasing hormone interactions with growth hormone secretion in horses
J Anim Sci, September 1, 2003; 81(9): 2343 - 2351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. V. Dimaraki, C. A. Jaffe, C. Y. Bowers, P. Marbach, and A. L. Barkan
Pulsatile and nocturnal growth hormone secretions in men do not require periodic declines of somatostatin
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E163 - E170.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Richmond, A. D. Rogol, D. Basdemir, O. L. Veldhuis, W. Clarke, C. Y. Bowers, and J. D. Veldhuis
Accelerated Escape from GH Autonegative Feedback in Midpuberty in Males: Evidence for Time-Delimited GH-Induced Somatostatinergic Outflow in Adolescent Boys
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3837 - 3844.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. S. Farhy, M. Straume, M. L. Johnson, B. Kovatchev, and J. D. Veldhuis
A construct of interactive feedback control of the GH axis in the male
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R38 - R51.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. V. Dimaraki, C. A. Jaffe, R. Demott-Friberg, M. Russell-Aulet, C. Y. Bowers, P. Marbach, and A. L. Barkan
Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiator
Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E489 - E495.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Lanneau, M. T. Bluet-Pajot, P. Zizzari, Z. Csaba, P. Dournaud, L. Helboe, D. Hoyer, E. Pellegrini, G. S. Tannenbaum, J. Epelbaum, et al.
Involvement of the Sst1 Somatostatin Receptor Subtype in the Intrahypothalamic Neuronal Network Regulating Growth Hormone Secretion: An in Vitro and in Vivo Antisense Study
Endocrinology, March 1, 2000; 141(3): 967 - 979.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Beranek, I. Hajdu, J. Gardi, P. Taishi, F. Obal Jr., and J. M. Krueger
Central administration of the somatostatin analog octreotide induces captopril-insensitive sleep responses
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1999; 277(5): R1297 - R1304.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Giustina and J. D. Veldhuis
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human
Endocr. Rev., December 1, 1998; 19(6): 717 - 797.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Beranek, F. Obal Jr., P. Taishi, B. Bodosi, F. Laczi, and J. M. Krueger
Changes in rat sleep after single and repeated injections of the long-acting somatostatin analog octreotide
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1484 - R1491.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the Society for Endocrinology.